Home
About
Overview
Sharing Data
ORCID
Help
History (32)
Systems Integration
Remission, Spontaneous
Vasoactive Intestinal Peptide
Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features.
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model.
See All 32 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model.
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model. J Cell Mol Med. 2020 01; 24(2):1738-1749.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Brain Neoplasms
Cell Line, Tumor
Chickens
Glioblastoma
Humans
Mice
Microvessels
Receptors, G-Protein-Coupled
Receptors, Notch
Tumor Burden
Xenograft Model Antitumor Assays
authors with profiles
James Battiste
Kar-Ming Fung
Megan Ross Lerner
Rafal Konrad Gulej
Jonathan D. Wren